The FDA Will Approve How Many New Drugs in 2012?
Published: Jul 27, 2012
Maybe not as many as last year, at least according to Fitch Ratings. In a new report, the ratings service notes that the FDA is on track to approve fewer drugs than in 2011, when 30 new primary care and specialty medicines were cleared for marketing. And while 2012 started strong with eight new molecular entities endorsed in the first quarter, the total of 14 new approvals in the first half of the year lags behind the 18 new medicines in the same period in 2011.